-+ 0.00%
-+ 0.00%
-+ 0.00%

Revelation Biosciences Announces 1-For-7 Reverse Stock Split, Effective Oct. 20

Benzinga·10/16/2026 13:03:22
Listen to the news

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today that, on October 20, 2026, the Company will implement a 1-for-7 reverse split of its common stock. The reverse stock split will be effective as of the morning of October 20, 2026, and the Company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol "REVB."